Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
Quick Stats
Jun 23, 202661.1
AI Score
BUY0.85
Volume Ratio
Aug 06, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
INSM Stock Summary
Last updated Jun 23, 2026
INSM is currently trading at $102.15, positioned below its 200-day moving average of $153.19, suggesting bearish momentum. The stock has a 52-week range of $90.39 to $212.75.
Technical Analysis: The 50-day moving average stands at $117.12, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.002, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.044, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates INSM at 61.1/100 with a BUY recommendation.
INSM (Insmed, Inc.) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.002 |
| CMF (20) | -0.044 |
| ROC (10) | 8.474 |
| ADX (14) | 42.84 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -5.153 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -21.074 |
| MFI (14) | 43.873 |
INSM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
INSM Price vs Max Options Open Interest
INSM Max Change In Options Open Interest
INSM Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INSM Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INSM Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INSM Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Insmed, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
INSM Moving Averages Analysis
INSM (Insmed, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 97.35 |
| 20 | 100.55 |
| 30 | 103.73 |
| 50 | 117.12 |
| 100 | 133.83 |
| 200 | 153.19 |
INSM Fundamental Analysis
| P/E (Forward) | 16.3666 |
| P/E (Trailing) | -- |
| Market Cap ($) | 21.4 billion |
| Earnings/Share ($) | -5.76 |
| Net Proft Margin (%) | -1.4444 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.7064 |
| EPS Estimate Next Year ($) | 0.2541 |
| WallStreet Target Price ($) | 197.1429 |
| Most Recent Quarter |